Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

Share Price is delayed by 15 minutes
Get Live Data
156.00    -1.50 (-0.95%)
Bid:
152.00
Ask:
160.00
Spread: 8.00 (5.263%)
Market Cap: £183.02m
SUP Live PriceLast checked at - London Stock Exchange

Intraday Supreme Plc Share Chart

Director Share Purchase

4 Oct 2023 10:50

RNS Number : 6863O
Supreme PLC
04 October 2023
 

4 October 2023

 

Supreme plc

("Supreme," the "Company" or the "Group")

 

Director Share Purchase

Supreme (AIM:SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, has been notified on 3 October 2023 that, Sandeep Singh Chadha, Chief Executive Officer, purchased the following Ordinary Shares in the Company:

Date of purchase

Ordinary Shares purchased

Price per Ordinary Share (£)

02/10/2023

1,570

1.25

02/10/2023

153,430

1.26674

29/09/2023

65,000

1.23862

Total:

220,000

 

The above acquisitions were made by Supreme 8 Limited, a company wholly owned by Mr Chadha.

In addition, the Company has been notified on 3 October 2023 that the Chadha Discretionary Trust 2020, a person closely associated (PCA) of Sandeep Singh Chadha, Chief Executive Officer, purchased the following Ordinary Shares in the Company:

Date of purchase

Ordinary Shares purchased

Price per Ordinary Share (£)

02/10/2023

50,000

1.2815

29/09/2023

30,000

1.235

29/09/2023

90,000

1.178778

Total:

170,000

 

Following these purchases, Mr. Chadha now has a total beneficial interest in 67,266,845 Ordinary Shares, representing 57.34% of the current issued share capital of the Company.

The Group's current share capital consists of 117,321,126 Ordinary Shares with voting rights.

Further details of the PDMR dealing are included below. This information has been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

1

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

Sandeep Singh (Sandy) Chadha

2

Reason for the notification

a)

Position/status

CEO / PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Supreme plc

b)

LEI

213800DBHCI5WQWECL16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 Ordinary Shares

 

 

GB00BDT89C08

 

b)

Nature of the transaction

Direct purchase of shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.25

1.26674

1.23862

1,570

153,430

65,000

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

220,000 Ordinary Shares

£276,828.72

e)

Date of the transaction

29 September 2023 - 2 October 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

the Chadha Discretionary Trust 2020

2

Reason for the notification

a)

Position/status

PCA of Sandeep Singh (Sandy) Chadha CEO / PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Supreme plc

b)

LEI

213800DBHCI5WQWECL16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 Ordinary Shares

 

 

GB00BDT89C08

 

b)

Nature of the transaction

Direct purchase of shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

1.2815

1.235

1.178778

 

50,000

30,000

90,000

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

170,000 Ordinary Shares

£207,215.02

e)

Date of the transaction

29 September 2023 - 2 October 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

Enquiries:

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

 

Grant Thornton UK LLP (Nominated Adviser)

Samantha Harrison / Harrison Clarke / Samuel Littler

 

+44 (0)20 7383 5100

Berenberg (Broker)

Mark Whitmore / Mara Grasso

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, The Range, Sainburys, Sports Direct, Londis, SPAR, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.  

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness.

 

investors.supreme.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFSAIDLSIIV
Date   Source Headline
12th Jul 20229:30 amRNSHolding(s) in Company
12th Jul 20229:19 amRNSDirector Share Purchase
8th Jul 20225:14 pmRNSHolding(s) in Company
6th Jul 202212:34 pmRNSHolding(s) in Company
5th Jul 202211:05 amRNSSecond Price Monitoring Extn
5th Jul 202211:00 amRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSFinal Results
21st Jun 20227:00 amRNSNotice of Results & Investor Presentation
13th Jun 20227:00 amRNSAcquisition of Liberty Flights Holdings Limited
10th May 20227:00 amRNSSale of McColl's Retail Group
28th Apr 202212:35 pmRNSHolding(s) in Company
14th Apr 202212:00 pmRNSInvestor Presentation
12th Apr 20229:05 amRNSSecond Price Monitoring Extn
12th Apr 20229:00 amRNSPrice Monitoring Extension
12th Apr 20227:00 amRNSYear End Trading Update
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:01 pmRNSPrice Monitoring Extension
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSHalf-year Results
30th Nov 202111:30 amRNSInvestor Presentation
18th Oct 20217:07 amRNSTrading Update & Notice of Results
30th Sep 20213:05 pmRNSResults of AGM
31st Aug 20217:00 amRNSAvailability of Annual Report & Notice of AGM
20th Jul 20217:00 amRNSUnaudited Preliminary Results
19th Jul 20217:00 amRNSLaunch of Sealions Vitamin brand
8th Jul 20217:00 amRNSNotice of Results & Investor Presentation
1st Jul 20217:00 amRNSAcquisition of brands of SCI-MX Limited
11th Jun 20217:00 amRNSAcquisition of Vendek Limited
9th Jun 20217:00 amRNSExercise of options and total voting rights
4th May 20217:00 amRNSTrading Update
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
19th Mar 20211:13 pmRNSGrant of Options under 2021 SAYE Scheme
15th Mar 20217:00 amRNSCompletion of McColl’s roll-out
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20219:00 amRNSPrice Monitoring Extension
2nd Feb 20214:37 pmRNSHolding(s) in Company
1st Feb 20217:00 amRNSAIM Admission & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.